arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 5/2024 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    THERAPY FROM A CRITICAL VIEWPOINT

    Beta blockers after myocardial infarction with preserved ejection fraction?

    NEW ON THE MARKET

    Neurokinin-3 (NK3) antagonist fezolinetant (VEOZA) against hot flushes?

    Anti-CD20 antibody ublituximab (BRIUMVI) for multiple sclerosis

    IN BRIEF

    New study: D-mannose against urinary tract infections?

    Rivaroxaban (XARELTO) – patent expiry and generics in installments

    Listeriosis due to vegan cheese substitute

    Intensive care patients: brushing teeth to protect against nosocomial pneumonia

    Classification of foods for special medical medical purposes

    SIDE EFFECTS

    Suicidality with GLP-1 agonists – risk signal not confirmed
    free

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!